Evidence map›Paper›PMID 31235712›Full record

ArticleScientific reports2019

An Improved Method for Fabrication of Ag-GO Nanocomposite with Controlled Anti-Cancer and Anti-bacterial Behavior; A Comparative Study.

Sadegh Khorrami, Zahra Abdollahi, Ghazaleh Eshaghi, Arezoo Khosravi, Elham Bidram, Ali Zarrabi

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Probiotic potential and anticancer properties ofBiotechnology reports (Amsterdam, Netherlands) · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sadegh KhorramiDepartment of Biotechnology, Facullty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran.ORCID http://orcid.org/0000-0002-1396-1316
Zahra AbdollahiDepartment of Biotechnology, Facullty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran.
Ghazaleh EshaghiDepartment of Biotechnology, Facullty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran.
Arezoo KhosraviDepartment of Mechanical Engineering, Khomeinishahr Branch, Islamic Azad University, Khomeinishahr/Isfahan, Iran.
Elham BidramDepartment of Biotechnology, Facullty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran.
Ali ZarrabiDepartment of Biotechnology, Facullty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran. alizarrabi@sabanciuniv.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, two green procedures for Silver-Graphene Oxide (Ag-GO) nanocomposite synthesis were investigated. As a common method, AgNO

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsGraphiteHumansMCF-7 CellsMetal NanoparticlesNanocompositesSilverAnti-Bacterial AgentsAntineoplastic Agentsgraphene oxideGraphiteSilver

Identifiers

PMID31235712
PMCPMC6591237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.